In the SURPASS-2 trial, tirzepatide demonstrated greater HbA1c reduction and weight loss compared to semaglutide 1 mg in type 2 diabetes
The MHRA has approved Ozempic specifically for diabetes management, not for weight loss (which would be an off-label use), though its sister product Wegovy (also semaglutide) is licensed for weight management
Obesity is closely associated with an increased risk of multiple cancers, and NNMT overexpression acts as a key mediator linking obesity and cancer: in the obese state, elevated NNMT activity leads to metabolic disorders and promotes cancer cell proliferation.By inhibiting NNMT activity, 5-amino-1mq liquid regulates systemic metabolism, reduces fat accumulation, and suppresses the occurrence and progression of obesityrelated cancers, providing a novel strategy for the prevention and treatment of such cancers
GLP-1 medications make this easier by reducing hunger
However, everyones experience is different